Opinion
Published on 11 Jul 2025
Oncolytic virus VG161 offers new hope for refractory liver cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1605177
- 392 views
Type at least 3 characters
1,439 articles
Mini Review
Published on 10 Jul 2025
Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1620501
- 263 views
Original Research
Published on 09 Jul 2025
Association of visceral obesity indicators with prostate cancer: a cross-sectional study from Xinjiang
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1614743
- 332 views
Original Research
Accepted on 08 Jul 2025
Association between emotional distress and the efficacy of advanced gastric cancer patients undergoing treatment with immune checkpoint inhibitors: A cohort study and propensity score matching study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1516643
Review
Published on 08 Jul 2025
Shaping viral immunotherapy towards cancer-targeted immunological cell death
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1540397
- 563 views
Original Research
Published on 08 Jul 2025
Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell lung cancer patients undergoing anti-PD1 therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1628379
- 261 views
Original Research
Accepted on 07 Jul 2025
Single-cell sequencing combined with machine learning to identify glioma biomarkers and therapeutic targets
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1629102
- 113 views
Original Research
Accepted on 07 Jul 2025
Identification and Comprehensive Analysis of An Immune-Related Gene Prognostic Model for Indicating Tumor Immune Microenvironment Features in Soft Tissue Sarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1609501
Original Research
Accepted on 30 Jun 2025
Performance of the neutrophil-to-lymphocyte ratio as a prognostic tool for survival in solid cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1616477
- 107 views
Original Research
Accepted on 30 Jun 2025
Multiplexed Immune Profiling and 3D Co-culture Assays to Assess the Individual Checkpoint Therapy Response in Head and Neck Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1622008
Mini Review
Accepted on 26 Jun 2025
Deciphering spatially confined immune evasion niches in osteosarcoma with 3-D spatial transcriptomics: A literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1640645
- 150 views
Systematic Review
Accepted on 24 Jun 2025
Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1615795
- 149 views
Original Research
Published on 24 Jun 2025
Evaluating the immune response in a murine cancer model between irreversible electroporation and an advanced biphasic pulsed electric field technology
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1592610
- 410 views
Original Research
Accepted on 23 Jun 2025
Lactylation-related gene signatures identify glioma molecular subtypes with prognostic, immunological, and therapeutic implications
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1613423
Case Report
Accepted on 20 Jun 2025
Case Report: Personalized Peptide-Based Immunization in an Advanced-Stage Prostate Cancer Patient with Bone Metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1596315
Review
Accepted on 20 Jun 2025
Neurotransmitters: an emerging target for therapeutic resistance to
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1622759